Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
Syed Ehsan Shah, Hemostasis Key Account Manager at Werfen, shared on LinkedIn:
”This week in Basel, Switzerland Werfen EEMEA together with AFMS team hosted a one-day session on automation in Hemostasis laboratories for our customers from Saudi Arabia.
It was a great opportunity to share knowledge about Werfen Hemostasis Solutions for big specialized hemostasis centers and explore how Werfen automation-HemoCell can truly transform daily hemostasis lab operations.
In the afternoon, participants had the chance to see the HemoCell automation in action in Basel University.
The laboratory supervisor shared valuable insights, highlighting key advantages such as:
- Less than 30 minutes turnaround time
- Full sample traceability
- Complex reflex rules for factor assays
- Reduced staff workload
A big thanks to all the participants and our team members who joined and contributed to the discussions — it’s always inspiring to see how Werfen innovation in Hemostasis continues to enhance lab efficiency and patient care.
Special thanks to Elias Bouchi, Gianpaolo Pozzato and Ahmed Abbas for your support and dedication.”
Stay updated with Hemostasis Today.
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Grateful to Be Connecting with so Many Families and Advocates at HFA 2026 in New Orleans
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge
-
May 6, 2026, 02:12Caitlin Raymond: How STOP-BABESIOSIS Just Rewrote 40 Years of Practice
-
May 5, 2026, 16:28Nikolay Novitski: A New Era in Cardiovascular Prevention
-
May 5, 2026, 16:23Satyam Arora: Best Abstract Award in Pediatric Apheresis at ASFA 2026 Congress
-
May 5, 2026, 16:17Hannah Omunakwe: Your Sick Child Has a Clot. Did You See That Coming?
-
May 5, 2026, 15:57Venous Thromboembolism Risk in Pregnancy and the Postpartum Period – NBCA